Patents Assigned to Max-Delbruck-Zentrum fur Molekulare Medizin
  • Therapeutic agent for the treatment of septicaemia its preparation and use
    Patent number: 6949512
    Abstract: A therapeutic agent for the treatment of septicemia, its preparation and use, with application in the pharmaceutical industry and medicine. This therapeutic agent contains essential element, the lipopolysaccharide binding protein (LBP). Also disclosed are LBP variants, mutants and hybrid proteins. Murine or rabbit LBP may also be used, besides human LBP.
    Type: Grant
    Filed: January 13, 2000
    Date of Patent: September 27, 2005
    Assignee: Max-Delbruck-Zentrum fur Molekulare Medizin
    Inventors: Ralf Reiner Schumann, Norbert Lamping
  • Antitumor cystostatic and contrast agent
    Patent number: 6479033
    Abstract: The invention concerns a composition for the treatment of tumors, of (i) at least one cytostatic drug component which is unencapsulated or is encapsulated in a PEG-, immuno-, or immuno/PEG liposome, (ii) at least one of lyophilized starch particles, degradable starch particles, and gelatine, in combination with (iii) a contrasting agent containing at least one of iodine, gadolinium, and magnetite.
    Type: Grant
    Filed: June 16, 1997
    Date of Patent: November 12, 2002
    Assignee: Max Delbrück Zentrum für Molekulare Medizin
    Inventors: Regina Reszka, Uwe Pohlen, Detlef Stiller, Gerd Berger, Matthias Lippmann